The Most Important Advances in Precision Medicine Being Presented at ASCO 2018

David Spigel, MD

Dr David Spigel reviews 3 of the most important, practice-changing topics at ASCO 2018: new therapies targeting RET in a number of tumor types, a prognostic biomarker assay to predict whether patients with breast cancer will need adjuvant hormonal therapy or chemotherapy, and the minimum level of PD-L1 positivity required to predict outcomes with immunotherapy in lung cancer.

Related Videos

December 12, 2016

Patient Preferences

Sunil Verma, MD, MSEd, FRCPC takes up the topic of communicating with patients about what they want for their care.

January 20, 2016

Do Therapeutic Agents Affect Healthy Stem Cells?

Dr Wainberg and Dr Gerson ponder and provide opinions on whether these investigational therapies also target healthy cells.